Piedmont Capital Management (North Carolina)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Sell
1,848
-416
-18% -$97K 0.29% 60
2026
Q1
$553K Buy
2,264
+89
+4% +$20.7K 0.37% 44
2025
Q4
$450K Buy
+2,175
New +$430K 0.3% 54

Other funds holding JNJ

Piedmont Capital Management (North Carolina)'s JNJ Position: Q2 2026 in Review

Piedmont Capital Management (North Carolina) reduced its Johnson & Johnson (JNJ) stake by 18% in Q2 2026, selling an estimated $97K and leaving 1,848 shares worth $469K. The position accounts for 0.29% of the portfolio, ranked #60.

Piedmont Capital Management (North Carolina) first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $553K in Q1 2026. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Piedmont Capital Management (North Carolina) held 1,848 shares of Johnson & Johnson worth $469K as of Q2 2026.
  • Piedmont Capital Management (North Carolina) sold 416 Johnson & Johnson shares in Q2 2026, an estimated $97K.
  • Johnson & Johnson made up 0.29% of Piedmont Capital Management (North Carolina)'s portfolio in Q2 2026, its #60 holding.
  • Piedmont Capital Management (North Carolina) first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Piedmont Capital Management (North Carolina)'s Johnson & Johnson position peaked at $553K in Q1 2026.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Piedmont Capital Management (North Carolina)'s 13F filing for Q2 2026, filed 13 Aug 2026.